These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antigens and antibodies in malignant melanoma. Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169 [TBL] [Abstract][Full Text] [Related]
24. Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma. Kelley MC; Jones RC; Gupta RK; Yee R; Stern S; Wanek L; Morton DL Cancer; 1998 Oct; 83(7):1355-61. PubMed ID: 9762936 [TBL] [Abstract][Full Text] [Related]
25. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden. Morgan AC; Crane MM; Rossen RD J Natl Cancer Inst; 1984 Feb; 72(2):243-9. PubMed ID: 6582312 [TBL] [Abstract][Full Text] [Related]
26. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517 [TBL] [Abstract][Full Text] [Related]
27. Comparison of antibody isotypes in sera and circulating immune complexes during tumor growth and metastasis of three tumor models in mice. McDonald TL; Collins M; Talmadge JE Cancer Res; 1984 Nov; 44(11):4933-7. PubMed ID: 6435859 [TBL] [Abstract][Full Text] [Related]
28. Relationship between circulating immune complexes and urinary antigens in human malignancy. Huth JF; Gupta RK; Morton DL Cancer; 1982 Mar; 49(6):1150-7. PubMed ID: 7037157 [TBL] [Abstract][Full Text] [Related]
29. In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody. Stuhlmiller GM; Sullivan DC; Vervaert CE; Croker BP; Harris CC; Seigler HF Ann Surg; 1981 Nov; 194(5):592-601. PubMed ID: 6895297 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of serial determinations of circulating immune complex levels in malignant melanoma. Bukh A; Møller-Larsen A; Aguado MT; Møller-Larsen F; Møller NP Cancer Immunol Immunother; 1988; 26(3):280-4. PubMed ID: 3260134 [TBL] [Abstract][Full Text] [Related]
31. The functional role of the carbohydrate in human melanoma associated antigens. I. Antigen-antibody complex formation. Hakim AA; Siraki CM; Silvetti AN; Joseph CE Neoplasma; 1983; 30(4):411-9. PubMed ID: 6412146 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of a 90kD subunit containing glycoprotein tumor-associated antigen specific immune complexes in lung cancer patients. Gupta RK; Morton DL Dis Markers; 1994 Oct; 12(1):51-61. PubMed ID: 7842631 [TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients. Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161 [TBL] [Abstract][Full Text] [Related]
35. Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. Real FX; Mattes MJ; Houghton AN; Oettgen HF; Lloyd KO; Old LJ J Exp Med; 1984 Oct; 160(4):1219-33. PubMed ID: 6237165 [TBL] [Abstract][Full Text] [Related]
36. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice. Hwang KM; Fodstad O; Oldham RK; Morgan AC Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007 [TBL] [Abstract][Full Text] [Related]
37. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137 [TBL] [Abstract][Full Text] [Related]
39. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. Jones PC; Sze LL; Liu PY; Morton DL; Irie RF J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475 [TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma. Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]